Skip to content
ETopical – Lifestyle
Home
Sample Page
Author:
i-LUMEN SCIENTIFIC, Inc.
i-Lumen Scientific Announces First U.S. Patient Randomized in i-SIGHT2 Pivotal Study Evaluating Noninvasive Bioelectric Therapy for Intermediate to Advanced Dry AMD
July 21, 2026
i-Lumen Scientific Receives FDA Approval of IDE to Initiate U.S. Enrollment in i-SIGHT2 Clinical Study for dry AMD
March 31, 2026